NCT03265366View on ClinicalTrials.gov

Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 14, 2017

Primary Completion Date

January 24, 2020

Study Completion Date

January 24, 2020

Conditions
Allergic Bronchopulmonary Aspergilloses
Interventions
DEVICE

MRI

It will be performed on a 1.5-Tesla MR scanner (MAGNETOM Avanto, Siemens Healthcare, Erlangen, Germany), without injection or inhalation of contrast agent.

DEVICE

CT scan (standard reference)

It will be performed on a 16 (Sensation 16, Siemens®) or 64 channels (Definition 64, Siemens®), without contrast agent injection.

Trial Locations (1)

33604

CHU de Bordeaux, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03265366 - Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses | Biotech Hunter | Biotech Hunter